Literature DB >> 18547303

Genetics of melanoma predisposition.

J Lin1, T L Hocker, M Singh, H Tsao.   

Abstract

Over the past 10 years, our understanding of melanoma at the molecular level has blossomed with the advent of genomic technologies. The enormous enthusiasm for the Human Genome Project is slowly being replaced by an even greater excitement for the unravelling of disease genomes, including melanoma. In this review, we will consider some of the clinical implications of these genetic findings for both diagnostics and therapeutics.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18547303     DOI： 10.1111/j.1365-2133.2008.08682.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  10 in total

1.  Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.

Authors:  Hannah K Weir; Loraine D Marrett; Vilma Cokkinides; Jill Barnholtz-Sloan; Pragna Patel; Eric Tai; Ahmedin Jemal; Jun Li; Julian Kim; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

Review 2.  Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

Authors:  Foteini Chatzinasiou; Christina M Lill; Katerina Kypreou; Irene Stefanaki; Vasiliki Nicolaou; George Spyrou; Evangelos Evangelou; Johannes T Roehr; Elizabeth Kodela; Andreas Katsambas; Hensin Tsao; John P A Ioannidis; Lars Bertram; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2011-06-21       Impact factor: 13.506

Review 3.  Epidemiological and genetic factors underlying melanoma development in Italy.

Authors:  Giuseppe Palmieri; Maria Colombino; Milena Casula; Mario Budroni; Antonella Manca; Maria Cristina Sini; Amelia Lissia; Ignazio Stanganelli; Paolo A Ascierto; Antonio Cossu
Journal:  Melanoma Manag       Date:  2015-05-18

Review 4.  Genetic determinants of cutaneous melanoma predisposition.

Authors:  Durga Udayakumar; Bisundev Mahato; Michele Gabree; Hensin Tsao
Journal:  Semin Cutan Med Surg       Date:  2010-09

5.  The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.

Authors:  Karin Loser; Thomas Brzoska; Vinzenz Oji; Matteo Auriemma; Maik Voskort; Verena Kupas; Lars Klenner; Cornelius Mensing; Axel Hauschild; Stefan Beissert; Thomas A Luger
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

6.  New common variants affecting susceptibility to basal cell carcinoma.

Authors:  Simon N Stacey; Patrick Sulem; Gisli Masson; Sigurjon A Gudjonsson; Gudmar Thorleifsson; Margret Jakobsdottir; Asgeir Sigurdsson; Daniel F Gudbjartsson; Bardur Sigurgeirsson; Kristrun R Benediktsdottir; Kristin Thorisdottir; Rafn Ragnarsson; Dominique Scherer; Kari Hemminki; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Rafael Botella-Estrada; Virtudes Soriano; Pablo Juberias; Berta Saez; Yolanda Gilaberte; Victoria Fuentelsaz; Cristina Corredera; Matilde Grasa; Veronica Höiom; Annika Lindblom; Johannes J Bonenkamp; Michelle M van Rossum; Katja K H Aben; Esther de Vries; Mario Santinami; Maria G Di Mauro; Andrea Maurichi; Judith Wendt; Pia Hochleitner; Hubert Pehamberger; Julius Gudmundsson; Droplaug N Magnusdottir; Solveig Gretarsdottir; Hilma Holm; Valgerdur Steinthorsdottir; Michael L Frigge; Thorarinn Blondal; Jona Saemundsdottir; Hjördis Bjarnason; Kristleifur Kristjansson; Gyda Bjornsdottir; Ichiro Okamoto; Licia Rivoltini; Monica Rodolfo; Lambertus A Kiemeney; Johan Hansson; Eduardo Nagore; José I Mayordomo; Rajiv Kumar; Margaret R Karagas; Heather H Nelson; Jeffrey R Gulcher; Thorunn Rafnar; Unnur Thorsteinsdottir; Jon H Olafsson; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

Review 7.  Pathology and genomics of pediatric melanoma: A critical reexamination and new insights.

Authors:  Armita Bahrami; Raymond L Barnhill
Journal:  Pediatr Blood Cancer       Date:  2017-09-12       Impact factor: 3.167

8.  Identification of a melanoma susceptibility locus and somatic mutation in TET2.

Authors:  Fengju Song; Christopher I Amos; Jeffrey E Lee; Christine G Lian; Shenying Fang; Hongliang Liu; Stuart MacGregor; Mark M Iles; Matthew H Law; Neal I Lindeman; Grant W Montgomery; David L Duffy; Anne E Cust; Mark A Jenkins; David C Whiteman; Richard F Kefford; Graham G Giles; Bruce K Armstrong; Joanne F Aitken; John L Hopper; Kevin M Brown; Nicholas G Martin; Graham J Mann; D Timothy Bishop; Julia A Newton Bishop; Peter Kraft; Abrar A Qureshi; Peter A Kanetsky; Nicholas K Hayward; David J Hunter; Qingyi Wei; Jiali Han
Journal:  Carcinogenesis       Date:  2014-06-30       Impact factor: 4.944

9.  RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.

Authors:  Lucas Goedert; Cristiano G Pereira; Jason Roszik; Jessica R Plaça; Cibele Cardoso; Guo Chen; Wanleng Deng; Vashisht Gopal Yennu-Nanda; Wilson A Silva; Michael A Davies; Enilza M Espreafico
Journal:  Oncotarget       Date:  2016-06-14

10.  Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies.

Authors:  Durga Udayakumar; Hensin Tsao
Journal:  Genome Med       Date:  2009-10-27       Impact factor: 11.117
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.